Novartis Launches Innovation Prize for Assistive Tech

“Every day, patients with multiple sclerosis (MS) face difficult and unique mobility challenges that can make regular activities such as walking, speaking, and living out comfortable lives extremely difficult,” said John Tsai, Head of Global Drug Development and Chief Medical Officer, Novartis. “Novartis is deeply invested in this community, and it is our hope that…

Health Science Companies Can Apply to the Capital Access Advisory Program

The Call for Applications for the 2020 OBIO Capital Access Advisory Program (CAAP®) is now open. The deadline for applications is Wednesday, December 18, 2019 at 5:00pm EST. The Ontario Bioscience Innovation Organization’s CAAP is a unique, industry-led initiative that provides selected high-potential Ontario health science companies with mentoring, strategic guidance and access to an…